Expression of concern
Dopamine Blocks Stress-mediated Ovarian Carcinoma Growth
Paper Information
Record ID:
31312
Author(s):
Journal:
Publication Date:
April 29, 2011
Retraction Date:
August 02, 2021
(4.3 years years ago)
Subjects:
Institutions:
- Department of Gynecologic Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas
- Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, Texas
- Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas
- Department of Center for RNA Interference and Non-coding RNA, University of Texas MD Anderson Cancer Center, Houston, Texas
- Department of Medicine, Division of Hematology–Oncology, UCLA School of Medicine, Los Angeles, California
- Department of Psychology, University of Iowa, Iowa City, Department of Gynecology, University of Iowa, Iowa City, Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa
- School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin
- Radiation Biophysics Laboratory, NASA Johnson Space Center, University of Space Research Association, Houston, Texas
- Institute for Clinical and Translational Science General Hospital-Boyd Tower, Iowa City, Iowa
Country:
🇺🇸 United StatesArticle Type:
Publisher:
American Association for Cancer Research
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reasons:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1158/1078-0432.CCR-21-2117Citations (105)
105
Total Citations29
Post-Retraction(27.6%)
75
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
11
Within 1 year
7
After 2+ years
1376
Days since retraction (latest)
Paper citing Dopamine Blocks Stress-mediated Ovarian Carcinoma ...
Unknown Authors
Unknown Journal
Published: Unknown
Dopamine D2 receptor agonists abrogate neuroendocrine tumour angiogenesis to inhibit chemotherapy-refractory small cell lung cancer progression
Sk. Kayum Alam, Anuradha Pandit, Li Wang et al. (11 authors)
Cell Death and Disease
Open Access
Published: May 2025
1376 days after retraction
Dopamine D2 receptor agonists abrogate neuroendocrine tumour angiogenesis to inhibit chemotherapy-refractory small cell lung cancer progression
Sk. Kayum Alam, Anuradha Pandit, Li Wang et al. (9 authors)
Unknown Journal
Open Access
Published: Nov 2024
1197 days after retraction
Positive Inotropic Agents in Cancer Therapy: Exploring Potential Anti-Tumor Effects
Eduarda Ribeiro, Nuno Vale
Targets
Open Access
Published: Jun 2024
3 citations
3 citations
1046 days after retraction
Effects of Chronic Stress Stimulation on the Occurrence and Development of Tumors and the Regulatory Role of Chinese Medicine
Wenqin Guo, Rongzhen Shi
Journal of Experimental and Clinical Application of Chinese Medicine
Open Access
Published: Apr 2024
995 days after retraction
Anticancer Properties of Antipsychotic Drugs
Milica Borovčanin, Bojan Stojanović, Milica Dimitrijevic Stojanovic et al. (6 authors)
Interdisciplinary cancer research
Published: Jan 2024
882 days after retraction
Multi-omic screening of invasive GBM cells reveals targetable transsulfuration pathway alterations
Joseph H. Garcia, Erin Akins, Saket Jain et al. (17 authors)
Journal of Clinical Investigation
Open Access
Published: Nov 2023
20 citations
20 citations
836 days after retraction
Dopamine signaling from ganglion cells directs layer-specific angiogenesis in the retina
Justine H. Liang, Viktor Akhanov, Anthony D. Ho et al. (8 authors)
Current Biology
Open Access
Published: Aug 2023
13 citations
13 citations
739 days after retraction
Chronic stress accelerates glioblastoma progression via DRD2/ERK/β-catenin axis and Dopamine/ERK/TH positive feedback loop
Yan Wang, Xiang Wang, Kai Wang et al. (11 authors)
Journal of Experimental & Clinical Cancer Research
Open Access
Published: Jul 2023
16 citations
16 citations
704 days after retraction
Antiangiogenic Effect of Dopamine and Dopaminergic Agonists as an Adjuvant Therapeutic Option in the Treatment of Cancer, Endometriosis, and Osteoarthritis
Julieta Griselda Mendoza‐Torreblanca, Noemí Cárdenas‐Rodríguez, Jazmín Carro-Rodríguez et al. (12 authors)
International Journal of Molecular Sciences
Open Access
Published: Jun 2023
4 citations
4 citations
682 days after retraction
Tumour microenvironment and pituitary tumour behaviour
Pedro Marques, Márta Korbonits
Journal of Endocrinological Investigation
Published: Apr 2023
18 citations
18 citations
621 days after retraction
Depression and Cancer: The Inflammatory Bridge
Fernanda Leite, Ângela Leite
Unknown Journal
Published: Jan 2023
1 citation
1 citation
517 days after retraction
Multi-omics profiles refine L-dopa decarboxylase (DDC) as a reliable biomarker for prognosis and immune microenvironment of clear cell renal cell carcinoma
Kun Chang, Jiaqi Su, Chuanyu Li et al. (9 authors)
Frontiers in Oncology
Open Access
Published: Dec 2022
4 citations
4 citations
490 days after retraction
CBA strain mice as a model of spontaneous carcinogenesis
О. А. Бочарова, Р. В. Карпова, Е. В. Бочаров et al. (8 authors)
Russian Journal of Biotherapy
Open Access
Published: Oct 2022
1 citation
1 citation
454 days after retraction
Stress and cancer: The mechanisms of immune dysregulation and management
Yixin Liu, Sheng Tian, Biao Ning et al. (6 authors)
Frontiers in Immunology
Open Access
Published: Oct 2022
64 citations
64 citations
429 days after retraction
Cracking the enigma of adenomyosis: an update on its pathogenesis and pathophysiology
Sun‐Wei Guo
Reproduction
Open Access
Published: Sep 2022
44 citations
44 citations
407 days after retraction
Anticancer efficacy of endo- and exogenous potent ligands acting at dopaminergic receptor-expressing cancer cells
Anna Laskowska, Patrycja Kleczkowska
European Journal of Pharmacology
Published: Aug 2022
2 citations
2 citations
386 days after retraction
Neurotransmitters: Potential Targets in Glioblastoma
Qiqi Huang, Lishi Chen, Jianhao Liang et al. (5 authors)
Cancers
Open Access
Published: Aug 2022
23 citations
23 citations
380 days after retraction
Effect of chronic stress on tumorigenesis and development
Chen Wang, Yumeng Shen, Jiaping Ni et al. (5 authors)
Cellular and Molecular Life Sciences
Published: Aug 2022
14 citations
14 citations
379 days after retraction
Nano-sized polystyrene plastic particles affect many cancer-related biological processes even in the next generations; zebrafish modeling
Ekrem Sulukan, Onur Şenol, Alper Baran et al. (8 authors)
The Science of The Total Environment
Published: May 2022
29 citations
29 citations
302 days after retraction
The Inhibitory Effect of Selected D2 Dopaminergic Receptor Agonists on VEGF-Dependent Neovascularization in Zebrafish Larvae: Potential New Therapy in Ophthalmic Diseases
Natalia Kasica, Anna Święch-Zubilewicz, Katarzyna Saładziak et al. (5 authors)
Cells
Open Access
Published: Apr 2022
10 citations
10 citations
243 days after retraction
Plasma and ovarian metabolomic responses to chronic stress in female mice
Oana A. Zeleznik, Tianyi Huang, Chirag J. Patel et al. (14 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Jan 2022
2 citations
2 citations
155 days after retraction
ONC206 has anti-tumorigenic effects in human ovarian cancer cells and in a transgenic mouse model of high-grade serous ovarian cancer.
Katherine L. Tucker, Yajie Yin, Stuart-Allison Moffat Staley et al. (13 authors)
PubMed
Published: Jan 2022
5 citations
5 citations
152 days after retraction
Psychological intervention to treat distress: An emerging frontier in cancer prevention and therapy
Mei Yang, Zhe Zhang, Edouard C. Nice et al. (6 authors)
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Published: Dec 2021
24 citations
24 citations
129 days after retraction
Adhesion concept in cancer biology: local and central mechanisms (part 2)
О. А. Бочарова, В. Б. Матвеев, Е. В. Бочаров et al. (5 authors)
Russian Journal of Biotherapy
Open Access
Published: Dec 2021
3 citations
3 citations
122 days after retraction
Evaluation of the Differences in the Expression of Biogenic Amine-Related mRNAs and Proteins in Endometrioid Endometrial Cancer
Michał Czerwiński, Anna Bednarska‐Czerwińska, Nikola Zmarzły et al. (6 authors)
Journal of Clinical Medicine
Open Access
Published: Oct 2021
4 citations
4 citations
81 days after retraction
Catecholamines Mediate Psychologic Stress–Induced Cancer Progression
Daniel Galera Bernabé
Cancer Research
Open Access
Published: Oct 2021
23 citations
23 citations
74 days after retraction
Dopamine promotes the progression of AML via activating NLRP3 inflammasome and IL-1β
Hong Wang, Chen Zhang, Jinting Liu et al. (9 authors)
Human Immunology
Published: Sep 2021
11 citations
11 citations
37 days after retraction
Blood Vessels and Peripheral Nerves as Key Players in Cancer Progression and Therapy Resistance
Niccolò Roda, Giada Blandano, Pier Giuseppe Pelicci
Cancers
Open Access
Published: Sep 2021
24 citations
24 citations
34 days after retraction
Increasing Area Deprivation Index negatively impacts ovarian cancer survival
Demetra Hufnagel, Dineo Khabele, Fiona E. Yull et al. (7 authors)
Cancer Epidemiology
Open Access
Published: Aug 2021
37 citations
37 citations
21 days after retraction
Editor's Note: Dopamine Blocks Stress-mediated Ovarian Carcinoma Growth
Myrthala Moreno‐Smith, Chunhua Lu, Mian M.K. Shahzad et al. (14 authors)
Clinical Cancer Research
Open Access
Published: Aug 2021
1 citation
1 citation
1 days before retraction
Stress Hormones: Emerging Targets in Gynecological Cancers
G. Chen, Lei Qiu, Jinghai Gao et al. (8 authors)
Frontiers in Cell and Developmental Biology
Open Access
Published: Jul 2021
10 citations
10 citations
24 days before retraction
Biochemical and cytotoxic evaluation of latroeggtoxin‐VI against PC12 cells
Xiaochao Tang, Dianmei Yu, Haiyan Wang et al. (8 authors)
Journal of Biochemical and Molecular Toxicology
Published: May 2021
5 citations
5 citations
66 days before retraction
Network pharmacology-based and clinically relevant prediction of active ingredients and potential targets of Chinese herbs on stage IV lung adenocarcinoma patients
Jinfeng Liu, Jian Hao, Yangyang Niu et al. (4 authors)
Journal of Cancer Research and Clinical Oncology
Published: Apr 2021
6 citations
6 citations
122 days before retraction
Dopamine receptor D1 agonist inhibits glioblastoma via calpain‑mediated ER stress and mitochondrial dysfunction
Kang Yang, Ruixue Xu, Weidong Le
Oncology Reports
Published: Mar 2021
4 citations
4 citations
133 days before retraction
Norepinephrine inhibits migration and invasion of human glioblastoma cell cultures possibly via MMP-11 inhibition
Jing Zhong, Weiran Shan, Zhiyi Zuo
Brain Research
Open Access
Published: Jan 2021
16 citations
16 citations
187 days before retraction
Precise medication for tumor patients in the context of mental stress
Qishun Geng, Zhibo Shen, Yuanyuan Zheng et al. (6 authors)
Cell Transplantation
Open Access
Published: Jan 2021
213 days before retraction
Cancer and stress: NextGen strategies
Bai Cui, Fei Peng, Jinxin Lü et al. (14 authors)
Brain Behavior and Immunity
Open Access
Published: Nov 2020
95 citations
95 citations
270 days before retraction
Dopamine D1 Receptor in Cancer
Paweł Sobczuk, Michał Łomiak, Agnieszka Cudnoch‐Jędrzejewska
Cancers
Open Access
Published: Nov 2020
31 citations
31 citations
273 days before retraction
Chronic Stress Promotes Cancer Development
Shirui Dai, Yongzhen Mo, Yumin Wang et al. (12 authors)
Frontiers in Oncology
Open Access
Published: Aug 2020
291 citations
291 citations
348 days before retraction
Activation of dopamine receptor D1 inhibits glioblastoma tumorigenicity by regulating autophagic activity
Kang Yang, Minghai Wei, Zhaofei Yang et al. (10 authors)
Cellular Oncology
Published: Aug 2020
29 citations
29 citations
361 days before retraction
Ropinirole, a potential drug for systematic repositioning based on side effect profile for management and treatment of breast cancer
Emdormi Rymbai, Deepa Sugumar, J. Saravanan et al. (4 authors)
Medical Hypotheses
Published: Aug 2020
7 citations
7 citations
365 days before retraction
Corrigendum to “Dopamine and serotonin regulate tumor behavior by affecting angiogenesis” [Drug Resist. Updat. 17 (2014) 96–104]
Marloes A.M. Peters, Annemiek Walenkamp, Ido P. Kema et al. (6 authors)
Drug Resistance Updates
Open Access
Published: Jul 2020
1 citation
1 citation
368 days before retraction
The tumour microenvironment of pituitary neuroendocrine tumours
Pedro Marques, Ashley Grossman, Márta Korbonits
Frontiers in Neuroendocrinology
Published: Jun 2020
41 citations
41 citations
412 days before retraction
Potencjalne zastosowanie agonistów dopaminergicznych D2 w leczeniu VEGF-zależnych chorób oczu
Maciej Osęka, Katarzyna Saładziak, Agnieszka Jamrozy−Witkowska et al. (6 authors)
OphthaTherapy Therapies in Ophthalmology
Open Access
Published: Mar 2020
489 days before retraction
Physical exercise and catecholamines response: benefits and health risk: possible mechanisms
Joanna Kruk, Katarzyna Kotarska, Basil H. Aboul‐Enein
Free Radical Research
Open Access
Published: Feb 2020
75 citations
75 citations
544 days before retraction
Chitosan is a potential inhibitor of ovarian cancer: Molecular aspects
Maryam Chamani, Parisa Maleki Dana, Shahla Chaichian et al. (5 authors)
IUBMB Life
Open Access
Published: Dec 2019
3 citations
3 citations
587 days before retraction
Morphological Coordination: A Common Ancestral Function Unifying Neural and Non-Neural Signaling
Chris Fields, Johanna Bischof, Michael Levin
Physiology
Open Access
Published: Dec 2019
93 citations
93 citations
607 days before retraction
DOPAMINERGIC SYSTEM: STRESS, DEPRESSION AND CANCER (PART 2)
О. А. Бочарова, Е. В. Бочаров, V. G. Kucheryanu et al. (5 authors)
Russian Journal of Biotherapy
Open Access
Published: Dec 2019
2 citations
2 citations
609 days before retraction
G Protein-Coupled Receptors (GPCRs)-Mediated Calcium Signaling in Ovarian Cancer: Focus on GPCRs activated by Neurotransmitters and Inflammation-Associated Molecules
Dragoş Predescu, Sanda Maria Creţoiu, Dragoș Crețoiu et al. (7 authors)
International Journal of Molecular Sciences
Open Access
Published: Nov 2019
45 citations
45 citations
634 days before retraction
Quick Stats
Total Citations:
105
Years Since Retraction:
4.3 years
Open Access:
Yes
Last Checked:
Jul 24, 2025